Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Improved Pharma and Varda Space Industries conducting pharmaceutical experiments in space


News Image

Developing new tools and advancing pharmaceutical development is a key part of Improved Pharma’s mission

On board the rocket launch for the Transporter-8 Mission sat Varda’s satellite “W-Series 1”. Within the capsule sits the drug ritonavir, created by scientists at Improved Pharma and housed in engineering designed and built by Varda to conduct controlled experiments in microgravity. A little over an hour after launch, the satellite was deployed and acquisition of signal followed shortly. While in orbit, the drug will undergo melt/cool experiments to grow new crystals. In about a month, the capsule will return to earth, landing at a US Air Force range in Utah. After a successful recovery, the material will be analyzed to learn how ritonavir crystals grown in space differ from those grown on earth.

Why manufacture pharmaceuticals in space? By eliminating factors such as convection and sedimentation that influence crystallization in gravity, a molecule has the freedom to crystallize in different ways. These differences can lead to significant advantages such as controlled particle size, growth of crystals that can’t be grown on earth, or the invention of new polymorphic forms that could have properties more valuable than existing forms. And, once those crystals are grown in space, they can be used to seed crystallizations on earth to make more of the new form. More information about this exciting next-step in drug development can be found in recent articles in CNN and also in a deep dive report.

Developing new tools and advancing pharmaceutical development is a key part of Improved Pharma’s mission. In 2021, Improved Pharma had the unique opportunity to start polymorph screening research projects in close collaboration with Varda Space Industries with the intent of advancing pharmaceutical manufacturing. Their first joint research project was published in 2022 and announced the discovery of a new form of ritonavir. This research was recognized by Organic Process Research & Development as one of the top “remarkable accomplishments from the scientific literature that are expected to be relevant and important with future practical applications.” The research collaboration between Improved Pharma and Varda Space Industries will continue into future missions.

About Improved Pharma

Improved Pharma is a research, consulting, and information company dedicated to improving pharmaceutical methods, formulations, and processes. Services include solid-state form studies, formulation design, synchrotron techniques, analytical testing, and expert consulting for the development and defense of intellectual property matters. The company was founded in 2006 by Stephen and Sarah Byrn, who also founded SSCI. For more information about Improved Pharma’s services, please contact us at 1-765-463-9951 or info@improvedpharma.com.

About Varda Space Industries

Varda is a venture capital-backed company creating the first free-flying space stations and reentry vehicles ready-built for materials processing. Microgravity found in low Earth Orbit (LEO) makes it possible to precisely control the crystallization process during development and manufacturing to create valuable pharmaceutical products that cannot be created on Earth’s surface. Varda has raised $53m+ from a cadre of world-class venture capital firms including, but not limited to: Founders Fund, Lux Capital, Caffeinated Capital, Khosla Ventures, and General Catalyst. For more information about Varda please contact press@varda.com

Share article on social media or email:



Princeton Medspa Partners Acquires Genesis Medspa of Colorado Springs


Princeton focuses on partnering with highly successful and long-tenured medical spas precisely like Genesis.

Princeton Medspa Partners has completed its partnership with Genesis Medspa, a Colorado Springs-based aesthetic medical practice. The business was founded in 2007 by industry expert Dr. Lisa Jenks, M.D. Dr. Jenks has long been an influencer in the medical spa industry and was named to the advisory board of Skin Inc. in 2018. She also operates DermAesthetic Consulting, a successful consulting business that helps educate and train physicians interested in entering the medical aesthetics industry.

Genesis marks the fifth physician-owned medical spa acquired by Princeton Medspa Partners, and its seventh total acquisition. Princeton focuses on partnering with highly successful and long-tenured medical spas precisely like Genesis. Upon closing the deal, PMP CEO Nick Williams stated, “Genesis is far and away the highest-rated medical spa in Colorado Springs, and one of the best aesthetic medical practices in the state. The addition of this partnership to our company is another major feather in our hat.”

“I am very excited to transition my legacy to people that I can trust. The Genesis name means a lot to me, and I wanted to make sure that I partnered with a group that would continue its excellent reputation. I believe I have done just that,” said Dr. Jenks after the closing. “After meeting the Genesis team and seeing the passion and commitment each member has to a best-in-class client experience, I am confident that they are a perfect fit for the growing PMP family,” added Gary Bufalo, Jr., PMP Senior Vice President of Operations.

Princeton Medspa Partners has grown dramatically since Williams joined the organization in September of 2022, with him leading the company to more than double in size in both locations and revenue in his first nine months as CEO. “I am extremely proud of the growth of the company, but I am far prouder of the incredible quality of practices that we are attracting. Genesis is a great example of the high-quality assets that make up this organization, and why we are extremely excited about its future.” The company has significant experience in medspa operations and boasts winner of the Aesthetic Guide’s 2022 Lifetime Achievement Award, Francis Acunzo, as its President.

About Princeton Medspa Partners

Princeton Medspa Partners is a national aggregator of medspas and aesthetic medical practices. The company focuses its efforts on acquiring and managing provider owned and driven businesses, as well as franchise developments. The company currently owns/manages 10 corporate locations, with a significant number of new acquisition opportunities signed. Inquiries regarding the company can be directed toward Princeton Medspa Partners CEO Nick Williams at nwilliams@princetonmedspapartners.com. Inquiries to the investor board can be directed to Phil Piro at ppiro@princetonequity.com.

Share article on social media or email:

Lantana Consulting Group Announces the Appointment of New Board Member Chris LeGrand


Chris LeGrand

Lantana Consulting Group announces the appointment of Chris LeGrand to its Board of Directors, effective June 1, 2023. Chris is currently the CEO of BroadReach Group and brings extensive industry experience to the Board.

Lantana Consulting Group announces the appointment of Chris LeGrand to its Board of Directors, effective June 1, 2023. Chris is currently the CEO of BroadReach Group and brings extensive industry experience to the Board.

“Chris is an accomplished business leader. His long history of leading healthcare companies through rapid growth, coupled with his industry knowledge, makes him the ideal person for this role,” said Courtney Panaia-Rodi, Lantana Chief Executive Officer. “His expertise will be invaluable as we grow in a scalable, sustainable way. We are excited to have Chris on the Board and look forward to working closely with him.”

With over 30 years of business experience spanning public and private sector healthcare and life sciences industries globally, Chris brings an in-depth understanding of healthcare markets, long-standing relationships with clients and partners, and a proven track record of driving growth and impact.

“I am thrilled to be joining the Board of Lantana, a fast-growing, forward-thinking enterprise that is committed to improving healthcare management and delivery through information.” LeGrand said.

About Lantana Consulting Group

Lantana Consulting Group is a leader in health-data quality and integration, which increases access to health information across the spectrum of care delivery and management.

For More Information:

Web: http://www.lantanagroup.com

Email: info@lantanagroup.com

Share article on social media or email:

Dr. Donald Watenpaugh’s Top Two Recommendations for Safe, Effective and Evidence-based Strategies to Protect Yourself From the Dangers of Extreme Summer Heat


“We must educate and empower people to safely protect themselves from heat-related illness using controlled and self-limited exposures to heat”

Heat-related injury and death continue to increase in association with extreme heat events provoked by climate change. Projections portend the escalation of this trend. (https://www.studiovidenda.com/)

Despite the well-established protection from heat offered by acclimation/acclimatization, most public health information sources advise people to avoid heat entirely to mitigate the risk of heat-related illness. “We have a primordial, powerful, easily accessed, cost-free, yet underutilized tool to increase thermal tolerance and reduce the incidence of heat-related medical events: heat,” says Dr. Donald Watenpaugh, senior author of the recently published article, “Reduce Heat-related Illness and Death with a Tool at Our Doorstep.”

(https://www.researchgate.net/publication/371409377_Reduce_Heat-related_Illness_and_Death_with_a_Tool_at_Our_Doorstep).

Dr. Watenpaugh and his co-author, Dr. Robert Carter III, offers the following two simple and effective public health recommendations:

1.    Do not altogether avoid exposure to heat. “Instructing people to avoid heat exposure completely negates their innate and protective ability to acclimate to the heat,” says Dr. Watenpaugh. “Such guidance increases the risk of heat-related illness or death if/when they experience unanticipated heat exposure from an air conditioning failure, power outage, or other causes,” says Dr. Carter.

2.    Adapt and publicize safe ways for the public to heat acclimate. “We must educate and empower people to safely protect themselves from heat-related illness using controlled and self-limited exposures to heat,” says Dr. Watenpaugh. “Such generalized guidance must emphasize individualization to physical and medical limitations,” says Dr. Carter.

About the Author

Dr. Robert Carter III is a Colonel in the U.S. Army, an expert in human performance and physiology, and an adjunct professor of Emergency Medicine at the University of Texas Health, San Antonio, Texas.

Dr. Donald Watenpaugh is an Adjunct Professor in the Department of Physiology and Anatomy, University of North Texas Health Science Center, Fort Worth, Texas, and the Department of Bioengineering, University of Texas at Arlington. He is the Chief Creative Officer for Studio Videnda. Dr. Watenpaug’s scientific mantra is to let the data decide the experimental outcome, and in the art world, he asserts: Let the data inspire and drive the artistic outcome.

Share article on social media or email:

CISCRP & DIA Collaborate on 5K Run & Walk Event to Recognize Clinical Trial Volunteers


News Image

“The goal of our 5K event is to raise public awareness and appreciation for medical heroes, and to celebrate and honor them for giving the gift of participation in clinical research.”

The Center for Information and Study on Clinical Research Participation (CISCRP) and the Drug Information Association (DIA), two independent nonprofit organizations, are excited to announce the upcoming Medical Heroes Appreciation 5K Run & Walk in Boston. This event celebrates the volunteers and healthcare professionals who help make new treatments possible for everyone and aims to raise awareness about the important role that clinical research plays in advancing public health. CISCRP will host the Medical Heroes Appreciation 5K Run & Walk with the support of DIA, held in conjunction with DIA 2023, DIA’s Global Annual Meeting in Boston, June 25-29, 2023. The 5K event will take place on Tuesday, June 27, at Head Island Causeway at Castle Island, from 6:30- 7:30 AM. To register, visit https://www.eventbrite.com/e/journey-to-better-health-medical-heroes-appreciation-5k-run-walk-tickets-591516851827

“Medical Heroes are the millions of people who take part in clinical trials in an effort to help advance public health and the future of medicine,” says CISCRP’s Founder and Board Chair, Ken Getz. “The goal of our 5K event is to raise public awareness and appreciation for these individuals, and to celebrate and honor them for giving the gift of participation in clinical research.”

“We are excited to partner with CISCRP to host another Medical Heroes Appreciation 5K Run & Walk event at our Global Annual Meeting this year,” says Marwan Fathalla, President and Global Executive Officer, DIA. “We are hopeful that many of our members and other clinical research professionals attending DIA 2023 will participate in the 5K in appreciation of the clinical trial participants who help make new treatments possible.”

This event is being sponsored by Amicus Therapeutics, IQVIA, Javara, SDC, Parexel, Moderna, and StudyKik

Check-in on the day of the event, June 27th, begins at 6AM. The 5K Run & Walk will begin at 6:30. Racers will receive bibs, t-shirts, an athlete certificate, and the chance to win fun branded giveaways and raffle prizes. For more information about the 5K event, to volunteer, register, or become a sponsor, visit https://www.ciscrp.org/event/2022-medical-heroes-appreciation-5k-run-walk/

About CISCRP

CISCRP is a 501(c)(3) nonprofit organization dedicated to informing, educating, and engaging the public and patients as partners in the clinical research process. CISCRP provides a library of clinical research resources, programs, and services. Visit http://www.ciscrp.org for more information.

About DIA

DIA members represent the largest global network of life sciences professionals and stakeholders coming together to collaborate, discuss, and problem-solve challenges facing the life sciences field in an increasingly complex and interconnected world. These efforts aim to inspire better policies, regulations, science, research and development, and ultimately better patient outcomes worldwide. Learn more at https://www.diaglobal.org

Share article on social media or email:

The Tilt! at NeoCon in Chicago


The Tilt!

The Tilt!’s elegant design and affordable price point is something that we hope will allow everyone to afford to sit actively, so they will fall in love with the benefits that come along with this new, top-of-the-line chair,” – QOR360 founder, Dr. Turner Osler.

QOR360, the Vermont startup changing the way the world sits with its active sitting solutions, today announced the launch of its newest product: the Tilt! at NeoCon in Chicago. This comes as the result of six years of in depth research, customer feedback and design innovation in the active chair space.

The Tilt! features an organic buckwheat hull as the seat cushion, a natural, biodegradable filling, and is secured atop a base of wood, steel, and natural rubber, adding to the chair’s nature-forward design. Unlike the brand’s signature Ariel chair, the Tilt! does not use the patented RedRocker technology; opting for a single industrial grade natural rubber motor-mount, which allows for 360 degrees of motion, without a gas cylinder, and including less parts. The Tilt! retails at $350, a lower and more affordable price compared to the brand’s signature, award-winning Ariel 2.0, which costs approximately $500. Its compact size allows users to easily store it when the product is not being used.

The pre-sale for the Tilt! ran through the month of April, to a strong reception and demand from existing customers. Shipping of the preorders is expected to begin in June 2023. Similar to the previous models of QOR360 chairs, the Tilt! encourages users to sit with balanced posture and engage their core muscles, resulting in improved posture, a stronger core, reduced back pain, and better metabolic health. The Tilt! promotes enhanced attention and greater alertness, making it a perfect addition to any workspace.

“The Tilt!’s elegant design and affordable price point is something that we hope will allow everyone to afford to sit actively, so they will fall in love with the benefits that come along with this new, top-of-the-line chair,” said QOR360 founder, Dr. Turner Osler.

QOR360 will be offering demos throughout the duration of NeoCon and welcomes any questions about the product and the brand. For more information about QOR360, visit QOR360.com

#####

About QOR360

QOR360 is located in Burlington, VT. Founded in 2016 by Dr. Turner Osler to change the way the world sits, QOR360 has introduced active sitting to the public through its patented Red Rocker™ Technology: an eccentric bi-cylinder, a shape that is central to QOR360’s ergonomic, healthy, and active seating products. Now, more than a half a decade in, QOR360 continues to introduce new active sitting concepts. Learn more at QOR360.com.

Share article on social media or email:

Oova, Inc. Announces Series A $10.3M and Launches New Oova Membership Model to Empower Women on their Reproductive Journeys


News Image

Oova, Inc., a trailblazer in women’s health and fertility solutions, is proud to announce its Series A raise of $10.3M, and introduce the new Oova Membership model, designed to provide unparalleled support and empowerment to women as they navigate fertility while trying to conceive. Unlike traditional one-time purchases or subscription-to-refill kits, the Oova Membership offers a comprehensive, ongoing solution for women’s reproductive health.

Oova, Inc founder and CEO, Amy Divaraniya, Ph.D., is an expert in biomedical sciences with a focus on genetics. Her personal struggles to conceive due to an irregular menstrual cycle emphasized the lack of resources women have to access instrumental information about their own bodies, leading Divaraniya to the development of Oova’s revolutionary technology. Oova is the only test on the market that quantitatively measures luteinizing hormone (LH) and progesterone (PdG) in real time, providing women with daily insights and actionable advice to optimize their chances of conception. It is FDA registered and the only product that allows its users to sync and share results with their doctor in real time. This innovative approach sets Oova apart, empowering women and their doctors with the knowledge they need to make informed decisions about their reproductive health. The Oova Kit launched in 2021 and has already trained its model on over 10,000 cycles monitored through the platform.

This round of funding brought on renowned investors across various industries and executive level expertise. It is led by Spero Ventures, a firm committed to companies with a positive mission, who are creating new markets and solutions for their customers.

“Oova has revolutionized the way we understand our hormonal health,” said Sara Eshelman, partner at Spero Ventures. “By making clinical-grade hormone monitoring convenient and cost-effective for daily use, Oova is empowering its users to understand their cycles, improve fertility outcomes, and manage their symptoms. Simultaneously, Oova offers intricate datasets that provide patients and clinicians an unprecedented objective understanding of how hormones affect our health and well-being. We are honored to be part of the team’s mission to bring these capabilities to women, and to clinical care as a whole.”

Spero Ventures is joined by other strategic firms including US Fertility, Virgin Group, Jefferson Health, Connecticut Innovations, Special Situations Life Sciences Fund, Samsung Next, Hannah Bronfman, and Sara Blakely, the acclaimed businesswoman and founder of Spanx.

“The US Fertility Innovation Fund is proud to partner with and invest in companies with the potential to transform the reproductive space. Oova is poised to do so by providing a more convenient and cost-effective way to measure reproductive hormones at home, “stated Dr. Eduardo Hariton, Managing Director of US Fertility Innovation Fund. “Their assays have been rigorously validated and provide accurate results in minutes, allowing them to meet the unique needs of both patients and providers without some of the hurdles of venipuncture.”

Understanding the evolving needs of women on their fertility journeys, Oova, Inc. is proud to launch the Oova Membership to address these needs holistically. Priced at $99 per month, the membership includes The Oova Kit ($159 value) and offers an array of features for women at every step of their fertility journey, including personalized support from Oova’s network of professionals.

Key features of the Oova Membership include:

Comprehensive Support: The membership grants access to the Oova Provider network, consisting of experienced healthcare professionals and hormone experts.

Personalized Guidance: Women receive tailored recommendations from hormone experts through consultations.

Community Connection: The Oova Membership fosters a vibrant and supportive community of like-minded women who are on similar journeys to parenthood. By engaging with this community, members can share their experiences, seek support, and forge valuable connections, creating a sense of camaraderie throughout their fertility journeys.

“We recognize that women seeking to start or expand their families desire more than just a test or a tool—they want a comprehensive solution,” said Divaraniya. “With the introduction of the Oova Membership, we are excited to provide women with a plan for the next steps in their journey to parenthood. By combining expert guidance, personalized recommendations, and a supportive community, we aim to empower women and ensure they have the tools they need to make informed decisions about their reproductive health.”

The launch of the Oova Membership reinforces Oova, Inc.’s commitment to revolutionizing women’s health and fertility solutions while being a beacon to help them navigate through each stage of their unique journey. Steadfast in their commitment to being the leading resource for women at the forefront of the femtech industry, the Oova team will continue to introduce access to new products and technology on their mission to address each phase of womanhood; from the beginning of menstruation, on the path to parenthood, and through menopause. To learn more about the Oova Membership and how it can support women on their fertility journeys, please visit oova.life.

For all media inquires, please contact Sara Spiegel at sara@withsarapr.com

For general inquiries, please contact info@oova.life

About Oova, Inc.:

Oova is the fertility translator that fully illuminates a woman’s fertility, giving her and her care team the clearest steps to conception. Founded by doctors and backed by Mount Sinai Hospital, Oova has created a consumer-first, data-driven experience valuable to patients and healthcare providers. Oova’s at-home urine test measures luteinizing hormone and progesterone to immediately inform a woman of her most fertile days and confirm ovulation. By delivering advanced personalized analytics and real-time action plans with every hormone reading, Oova is transforming the fertility care experience. Oova has partnered with the leading fertility and women’s health practices in the United States. To learn more, visit Oova’s website.

Share article on social media or email:

Navigating Your Repro Regulatory Questions


To mark the one-year anniversary of the US Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, healthcare law firm Nelson Hardiman LLP will present the webinar series Dobbs-One Year Later: Your Repro Regulatory Questions Answered. The first webinar in this series will be presented on Tuesday, June 27 beginning at 12 noon PDT.

When the Supreme Court overruled Roe v. Wade in the Dobbs decision on June 24, 2022, it denied the human right to abortion that has been precedent for decades and ended constitutional protections. Dobbs effectually gave each state the power to regulate abortion laws. As a result, in the past year, the healthcare landscape has become increasingly localized and complex to navigate. Simultaneously, the use of telehealth for medication abortion care (teleMAB) is increasingly significant and continues to grow as abortion providers think creatively about expanding access.

The series, Dobbs-One Year Later: Navigating Your Repro Regulatory Questions, will commence on June 27 with the webinar entitled “Understanding the Regulatory and Clinical Implications of Providing Reproductive Healthcare Services.” This initial webinar will cover the updates to the legal landscape for abortion providers, particularly focusing on telehealth for medication abortion, in the year post-Dobbs. We will give a broad overview of the legal frameworks that platforms, providers and healthcare practitioners must consider in order to ensure compliance with applicable state abortion and healthcare regulatory laws, including telehealth, scope of practice, and medication regulation.

The Dobbs-One Year Later series will be hosted by Founding Partner Harry Nelson and Of Counsel Natalie Birnbaum. Harry is regularly sought by many media outlets for his analysis of practical solutions to problems at the intersection of healthcare transformation, healthcare privacy, and regulatory compliance. Natalie works at the intersection of healthcare regulatory work, telehealth equity, reproductive rights, health, and justice. She frequently writes on the topic of telehealth for medication abortion for the American Health Law Association and owns a reproductive healthcare-focused policy consulting and legal advising firm, Repro Solutions PC.

There is no charge for this important and informative webinar. To register, please follow this link:

https://us02web.zoom.us/webinar/register/WN_C_PKqzUTTz6ueqgCGBy5Lg

Please join us on June 27 as we analyze this important and timely issue that is critical to the healthcare industry and the human right to bodily autonomy which will most certainly be a defining issue in the 2024 elections.

About Nelson Hardiman

Nelson Hardiman regularly advises clients on new healthcare law and compliance. The firm offers legal services to businesses at every point in the commercial stream of medicine, healthcare, and the life sciences. For more information, please contact us at nelsonhardiman.com.

Share article on social media or email:

Final List of Participating Startup Organizations at The Healthcare Innovation Congress, thINc360, Announced


The Healthcare Innovation Company (thINc) announced the final list of startup organizations that will be at its annual thINc360 conference, June 20-22, at the Grand Hyatt in Washington, D.C.

The Healthcare Innovation Congress, also known as thINc360, convenes leaders from health plans, health systems, public and private employers, life sciences, government, and public sector agencies to drive healthcare transformation forward. In collaboration with Enable Health, thINc is proud to unveil the startups at this year’s event:


Bitewell is a healthy food marketplace that works directly with employers to provide food health benefits, reducing insurance premiums and improving health for users.


A cancer diagnosis is a complicated and confusing time for individuals and their families. Cancer Expert Now applies data insights and the expertise of leading oncologists to provide the best possible member experience, improve outcomes, and reduce waste.


AcuDose solution is built on the principle of evidence-based community care. ConnectedPulse’s cloud server, mobile app and AcuDose verify and ensure correct on-time dosage. Patient’s dosage status is known to caregivers and loved ones in real– time so appropriate interventions can be offered to make sure that patients will adhere to their prescriptions.


Cubismi is pioneering the first and only AI-powered decision technology platform for precision medicine. Its cloud-based AI platform will empower radiologists to illuminate novel and optimal patient care pathways from massive medical datasets without the overload.


Developed by healthcare business executives for healthcare business executives, Doctivity delivers actionable insights derived from the application of proprietary analytics against a unique collection of business and healthcare datasets. Doctivity provides your business decision-makers with a comprehensive understanding of the dynamics of your healthcare ecosystem. Ongoing strategy meetings with Doctivity’s team of healthcare executives ensure client success.


DPNCheck® by NeuroMetrix® is an innovative point-of-care solution used by payors and providers for early detection and staging of peripheral neuropathy–which has ~30% prevalence rate among seniors and 50% among the diabetic population. DPNCheck provides accurate, objective, and reproducible data to help reduce costly complications, improve patient outcomes, and support accurate clinical and risk documentation.


Heal Security is the global authority for cybersecurity data, research, and insights across the healthcare sector. Its industry-specific platform provides actionable intelligence on cyber threats, risks, and remedies directly to the people protecting the delivery of healthcare services.

  • National Sports Health Network


The National Sports Health Network (NSHN) is a curated network of providers who specifically work with former elite athletes and connect them with extraordinary care and client experiences.


ORtelligence is revolutionizing the surgical process to ensure the successful delivery of surgical care. Its mission is to create cutting-edge software that aligns surgical teams with the right information, equipment, and support to deliver the best possible surgical care.


OxiWear is an ear-wearable, vital monitoring, and emergency alert accessory. Sleek, small, and modern, this device will allow you to obtain the medical assistance you need in an emergency. Oxiwear is committed to reducing patient vulnerability to hypoxic injury through wearable, continuous oxygen monitoring, increasing safety and peace of mind for those prone to silent hypoxia, helping to reduce healthcare costs, and saving lives.


Pluto Health strives to coordinate care and increase access to needed resources for people by leveraging quick access to data and insights in minutes, and then bringing together care coordination activities. Pluto Health’s team brings together siloed medical data, evaluates it, and works to address gaps in care for patients.


Radbutter is the only digital health solution supplementing radiology benefits with an AI-driven platform to identify at-risk patient populations qualified for clinically validated screening programs that reduce downstream treatment costs and optimize the balance between cost-savings and access to care.


Creating solutions that reimagine pathways to better health outcomes, RaiseHI designs proactively applied technologies and social strategies to engage a person before the need arises to enter “the four walls” of a healthcare facility. The current sick care operating model consists of reacting to symptoms after a person’s situation has escalated. RaiseHI’s objective is to shift that model from a reactive to a proactive and preventative approach that takes a holistic view of a person’s health in order to provide the vital support that’s required to circumvent a crisis altogether.


Scout is a medical device and health technology company developing an innovative platform for home and point of care (POC) diagnostic testing. The Scout platform combines patented chemistry, user-friendly software, and simple, portable hardware to allow for fast and accurate health data collection for a fraction of the price.


Stella Technology is a leading digital healthcare-only company on a mission. Stella believes that healthcare is a fundamental human right and wants to make high-quality care accessible and affordable for everyone on earth.


Talkie.ai offers voice AI solutions that enable medical centers, clinics, and hospitals to efficiently manage patient access through the phone. Their voice automation efficiently handles routine calls from patients, improving the overall patient experience.


ZeaHealth (A-Z Healthcare) – motto: All Healthcare Problems- One Solution Partner – is committed to disrupting healthcare to make it feel better – by delivering end-to-end solutions to enable healthcare organizations to be transparent, compliant, efficient, and highly reliable. ZeaHealth empowers people to purchase healthcare services with transparent healthcare pricing information and advises healthcare organizations on CMS compliance, co-management programs, value-based care, digital transformation, and graduate medical education programs.

The event includes a “Founders Forum” sponsored by Stella Technology where founding CEOs will be interviewed about their journeys as health innovators and entrepreneurs. Startups will also participate in a pitch competition similar to the television show, “Shark Tank,” where they will interact with a panel of investors.

“We are so excited for The Healthcare Innovation Congress. These startup organizations are disrupting the status quo and transforming the entire healthcare ecosystem. Their participation in thINc360 is the perfect complement to the changemakers who will be speaking and our national conference later this month,” said Haritha Krishnarathnam, VP of Content and Strategy, thINc.

Prospective attendees and sponsors can view the complete conference agenda and register at https://www.thinc360.com/2023event

About The Healthcare Innovation Congress (thINc360)

The Healthcare Innovation Congress, organized by The Healthcare Innovation Company, brings together two premier healthcare events – The World Health Congress for health plan, hospital system, government, and life sciences executives and Benefit Design Strategies for Employers (produced by Validation Institute) – together under one roof to form thINc360. Focused on delivering impactful content and creating meaningful connections, thINc360 gathers cross-sector healthcare leaders for the year’s most prominent industry event and offers a unique forum that inspires healthcare innovation.

The Healthcare Innovation Company: https://thinc360.com

Validation Institute: https://validationinstitute.com

Press Contact:

Reena Joseph

Director, Marketing and Partnerships

The Healthcare Innovation Company (thINc)

1-781-939-2446

Reena.Joseph@thinc360.com

National Board of Podiatric Medical Examiners (NBPME) Selects Meazure Learning for Development and Delivery of Its Licensing Exams


The contract award follows a stringent, months-long process of evaluating potential partners, during which Meazure Learning’s commitment to delivering the highest levels of service stood apart.

Meazure Learning, a leading provider of end-to-end test development and delivery solutions for professional testing and higher-education organizations, today announced it has been selected by the National Board of Podiatric Medical Examiners (NBPME) to develop and deliver the American Podiatric Medical Licensing Exam (APMLE) in a multi-year agreement.

The NBPME is a nonprofit organization that sets the policy, guides the development, and sponsors the administration of the licensing examination for podiatric medicine used throughout the United States. The high-stakes exam measures the important knowledge necessary to perform at the level of minimal competence as a newly licensed podiatric medical practitioner. 

The contract award follows a stringent, months-long process of evaluating potential partners, during which Meazure Learning’s commitment to delivering the highest levels of service stood apart. Meazure Learning will be responsible for administering the exam program beginning in May 2024 after a year of preparation and transition. 

Dr. Roland Ramdass, NBPME Board President, says, “The entire board met with key staff from Meazure Learning and were impressed with their professionalism and commitment to developing and delivering quality examinations in a manner that emphasizes excellent service to every candidate.”

Meazure Learning’s extensive assessment development and psychometric team will work closely with NBPME to ensure the exams remain a valid measure of test-taker knowledge and are delivered with high levels of service that allow test-takers to perform their best. The exam will be administered through the Meazure Exam Platform and available through Meazure Learning’s network of more than 650 professional test centers throughout the U.S.

“We are thrilled to have been chosen by the NBPME to develop and administer the prestigious APMLE series,” says Tim McClinton, Meazure Learning CEO. “We look forward to providing an exceptional user experience to NBPME and its stakeholders while maintaining the highest levels of quality and security through our market-leading assessment development and exam delivery services.”

About Meazure Learning

Meazure Learning provides secure, reliable, and convenient test development, administration, and delivery solutions for academic and professional credentialing programs. The tech-enabled services company combines human expertise with end-to-end software solutions to provide its suite of services and achieve the optimal testing experience. With remote, test center, hybrid, and event-based delivery capabilities, it adapts to the unique needs of each exam program and test-taker. Meazure Learning empowers its clients, test-takers, and industry leaders through its mission to move people forward in their educational, professional, and personal lives.

To learn more, visit Meazure Learning at meazurelearning.com.

Share article on social media or email: